These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 20922397

  • 21. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, Keeling J, Phillips A, Vos A, Plaschkes J.
    J Clin Oncol; 2000 Nov 15; 18(22):3819-28. PubMed ID: 11078495
    [Abstract] [Full Text] [Related]

  • 22. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
    Chiu SN, Ni YH, Lu MY, Lin DT, Lin KH, Lai HS, Chang MH.
    Pediatr Surg Int; 2003 Oct 15; 19(8):593-7. PubMed ID: 14556026
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V].
    Liu G, Liu B, Li K, Dong K, Xiao X.
    Zhonghua Er Ke Za Zhi; 2015 Feb 15; 53(2):119-23. PubMed ID: 25876687
    [Abstract] [Full Text] [Related]

  • 26. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin.
    Seo T, Ando H, Watanabe Y, Harada T, Ito F, Kaneko K, Horibe K, Sugito T, Ito T.
    Surgery; 1998 Apr 15; 123(4):407-14. PubMed ID: 9551066
    [Abstract] [Full Text] [Related]

  • 27. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
    Fuchs J, Rydzynski J, Hecker H, Mildenberger H, Bürger D, Harms D, V Schweinitz D, German Cooperative Liver Tumour Studies HB 89 and HB 94.
    Eur J Pediatr Surg; 2002 Aug 15; 12(4):255-61. PubMed ID: 12369004
    [Abstract] [Full Text] [Related]

  • 28. Tumor rupture in hepatoblastoma: A high risk factor?
    Pondrom M, Pariente D, Mallon B, Taque S, Branchereau S, Chardot C, Laithier V, Tabone MD, Lejeune J, Faure-Conter C, Saumet L, Vérité C, Aerts I, Brugières L, Fresneau B.
    Pediatr Blood Cancer; 2020 Sep 15; 67(9):e28549. PubMed ID: 32618436
    [Abstract] [Full Text] [Related]

  • 29. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB, Murawski M, McCabe AJ, Maibach R, Brugières L, Roebuck D, Fabre M, Zimmermann A, Otte JB, Sullivan M, Perilongo G, Childs M, Brock P, Zsíros J, Plaschkes J, Czauderna P, Aronson DC.
    Eur J Cancer; 2013 Aug 15; 49(12):2698-704. PubMed ID: 23683550
    [Abstract] [Full Text] [Related]

  • 30. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R, Cefalo G, Terenziani M, Polastri D, Bellani FF, Mazzaferro V.
    Pediatr Hematol Oncol; 2005 Aug 15; 22(3):189-98. PubMed ID: 16020101
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, de Camargo B, Zsiros J, Roebuck D, Zimmermann A, Aronson D, Childs M, Widing E, Laithier V, Plaschkes J, Pritchard J, Scopinaro M, MacKinlay G, Czauderna P.
    N Engl J Med; 2009 Oct 22; 361(17):1662-70. PubMed ID: 19846851
    [Abstract] [Full Text] [Related]

  • 33. Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
    Hu H, Zhang W, Zhang Y, Gao Y, Zhi T, Li F, Li J, Gu H, Liao R, Wu R, Huang D.
    Pediatr Blood Cancer; 2024 Jan 22; 71(1):e30693. PubMed ID: 37937320
    [Abstract] [Full Text] [Related]

  • 34. Hepatoblastoma: an oncological review.
    Roebuck DJ, Perilongo G.
    Pediatr Radiol; 2006 Mar 22; 36(3):183-6. PubMed ID: 16404556
    [Abstract] [Full Text] [Related]

  • 35. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR.
    Semin Oncol; 1996 Jun 22; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [Abstract] [Full Text] [Related]

  • 36. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF, Greenberg ML, Filler RM.
    J Pediatr Surg; 1997 Jul 22; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [Abstract] [Full Text] [Related]

  • 37. [Current data concerning neoadjuvant chemotherapy].
    Depierre A.
    Rev Pneumol Clin; 2006 Feb 22; 62 Spec no 1():1S11-3. PubMed ID: 16719148
    [No Abstract] [Full Text] [Related]

  • 38. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP.
    J Clin Oncol; 2006 Jun 20; 24(18):2879-84. PubMed ID: 16782927
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.